rs3810950

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020549.5(CHAT):​c.358G>A​(p.Ala120Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 1,610,550 control chromosomes in the GnomAD database, including 47,769 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 3040 hom., cov: 33)
Exomes 𝑓: 0.24 ( 44729 hom. )

Consequence

CHAT
NM_020549.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.34

Publications

69 publications found
Variant links:
Genes affected
CHAT (HGNC:1912): (choline O-acetyltransferase) This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010]
CHAT Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 6
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003578037).
BP6
Variant 10-49616573-G-A is Benign according to our data. Variant chr10-49616573-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128724.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.26 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHATNM_020549.5 linkc.358G>A p.Ala120Thr missense_variant Exon 2 of 15 ENST00000337653.7 NP_065574.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHATENST00000337653.7 linkc.358G>A p.Ala120Thr missense_variant Exon 2 of 15 1 NM_020549.5 ENSP00000337103.2

Frequencies

GnomAD3 genomes
AF:
0.180
AC:
27291
AN:
152026
Hom.:
3042
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0483
Gnomad AMI
AF:
0.268
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.158
Gnomad SAS
AF:
0.273
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.217
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.191
GnomAD2 exomes
AF:
0.207
AC:
51237
AN:
247220
AF XY:
0.218
show subpopulations
Gnomad AFR exome
AF:
0.0412
Gnomad AMR exome
AF:
0.143
Gnomad ASJ exome
AF:
0.243
Gnomad EAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.179
Gnomad NFE exome
AF:
0.244
Gnomad OTH exome
AF:
0.227
GnomAD4 exome
AF:
0.243
AC:
354143
AN:
1458404
Hom.:
44729
Cov.:
33
AF XY:
0.245
AC XY:
177619
AN XY:
725372
show subpopulations
African (AFR)
AF:
0.0391
AC:
1307
AN:
33398
American (AMR)
AF:
0.149
AC:
6638
AN:
44574
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
6407
AN:
26094
East Asian (EAS)
AF:
0.173
AC:
6848
AN:
39574
South Asian (SAS)
AF:
0.276
AC:
23678
AN:
85806
European-Finnish (FIN)
AF:
0.186
AC:
9899
AN:
53286
Middle Eastern (MID)
AF:
0.279
AC:
1608
AN:
5766
European-Non Finnish (NFE)
AF:
0.256
AC:
283627
AN:
1109676
Other (OTH)
AF:
0.235
AC:
14131
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
14171
28343
42514
56686
70857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9536
19072
28608
38144
47680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.179
AC:
27284
AN:
152146
Hom.:
3040
Cov.:
33
AF XY:
0.179
AC XY:
13322
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0482
AC:
2002
AN:
41566
American (AMR)
AF:
0.185
AC:
2822
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
812
AN:
3470
East Asian (EAS)
AF:
0.157
AC:
814
AN:
5170
South Asian (SAS)
AF:
0.273
AC:
1310
AN:
4806
European-Finnish (FIN)
AF:
0.182
AC:
1923
AN:
10588
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.249
AC:
16891
AN:
67944
Other (OTH)
AF:
0.190
AC:
401
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1113
2225
3338
4450
5563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.229
Hom.:
16272
Bravo
AF:
0.171
TwinsUK
AF:
0.257
AC:
953
ALSPAC
AF:
0.273
AC:
1054
ESP6500AA
AF:
0.0517
AC:
228
ESP6500EA
AF:
0.249
AC:
2144
ExAC
AF:
0.207
AC:
25173
Asia WGS
AF:
0.191
AC:
664
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Aug 04, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 22, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Familial infantile myasthenia Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 11, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
13
DANN
Benign
0.84
DEOGEN2
Benign
0.070
.;.;.;T;.
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.58
.;.;T;T;T
MetaRNN
Benign
0.0036
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
.;.;.;N;.
PhyloP100
1.3
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.030
N;N;N;N;N
REVEL
Benign
0.10
Sift
Benign
0.13
T;T;T;T;T
Sift4G
Benign
0.12
T;T;T;T;T
Polyphen
0.014
.;.;.;B;.
Vest4
0.22
MPC
0.24
ClinPred
0.0033
T
GERP RS
3.0
Varity_R
0.026
gMVP
0.17
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3810950; hg19: chr10-50824619; COSMIC: COSV60321229; COSMIC: COSV60321229; API